Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

BIO-TECHNE (TECH) Other Gross PP&E Adjustments: 2010-2025

Historic Other Gross PP&E Adjustments for BIO-TECHNE (TECH) over the last 13 years, with Sep 2025 value amounting to $412.3 million.

  • BIO-TECHNE's Other Gross PP&E Adjustments rose 11.18% to $412.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 14.39%. This contributed to the annual value of $458.5 million for FY2025, which is 15.78% up from last year.
  • Per BIO-TECHNE's latest filing, its Other Gross PP&E Adjustments stood at $412.3 million for Q3 2025, which was down 10.06% from $458.5 million recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Other Gross PP&E Adjustments registered a high of $458.5 million during Q2 2025, and its lowest value of $275.6 million during Q3 2021.
  • Moreover, its 3-year median value for Other Gross PP&E Adjustments was $376.4 million (2024), whereas its average is $377.8 million.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first climbed by 23.27% in 2021, then declined by 5.67% in 2023.
  • BIO-TECHNE's Other Gross PP&E Adjustments (Quarterly) stood at $311.7 million in 2021, then rose by 4.21% to $324.8 million in 2022, then grew by 4.44% to $339.2 million in 2023, then grew by 16.99% to $396.9 million in 2024, then increased by 11.18% to $412.3 million in 2025.
  • Its Other Gross PP&E Adjustments stands at $412.3 million for Q3 2025, versus $458.5 million for Q2 2025 and $428.1 million for Q1 2025.